Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link t...

von Talotta, Rossella
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2021)